Posted by AGORACOM-JC
at 4:31 PM on Wednesday, December 16th, 2020
Kontrol Energy Corp. ( CSE: KNR ) ( OTCQB: KNRLF ) ( FSE: 1K8 ) will be hosting a webinar presentation for investors, analysts and media for its Covid-19 detection technology (“BioCloud analyzer” or “BioCloud”). The purpose of the presentation is to provide an operating demonstration and take questions from the audience.
“Following the filing of our patent applications we are excited to demonstrate how the BioCloud technology operates and share that with the public,” says Paul Ghezzi , CEO Kontrol. “We will be providing a demonstration of BioCloud and access to the inner workings of the technology.”
Title: Kontrol to host BioCloud technology presentation for investors, analysts and media
Event date: Thursday, Dec. 17, 2020, at 4:30 p.m. Eastern Time
Presentation type: audio with presenter controlled slides and teleconference
Posted by AGORACOM-JC
at 4:13 PM on Wednesday, December 16th, 2020
Announced the completion of its first commercial production of the Shir premium cosmetic line and Relief & Go topicals in Portugal and is pleased to announce the commencement of production in the United States, for the first time
Innocan has successfully completed its first commercial manufacturing run of in Europe/Portugal and will commence a first manufacturing run in North America.
In Portugal, InnoCan has now a storage of 35,000 Units of our SHIR™ and Relief & Go™ line and will commence a first manufacturing run in North America, effective immediately to manufacture an initial stock of 40.000 units.
These production activities will enable the Company to deliver product to the European and US markets accordingly.
Herzliya, Israel and Calgary, Alberta–(December 16, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the “Company” or “Innocan”), is pleased to announce the completion of its first commercial production of the Shir premium cosmetic line and Relief & Go topicals in Portugal and is pleased to announce the commencement of production in the United States, for the first time.
Innocan has successfully completed its first commercial manufacturing run of in Europe/Portugal and will commence a first manufacturing run in North America. In Portugal, InnoCan has now a storage of 35,000 Units of our SHIR™ and Relief & Go™ line and will commence a first manufacturing run in North America, effective immediately to manufacture an initial stock of 40.000 units. These production activities will enable the Company to deliver product to the European and US markets accordingly.
Innocan sees this manufacturing advance as a major milestone in the Company’s commercialization, while maintaining a consistent and high-quality product. Innocan’s next step will be to produce additional inventory to service the Company’s expansion into the U.S. market as it rapidly expands into retail distribution and scales its online sales.
“We are moved by the immense and positive market-response to our long awaited product launch and are pleased to have the ability to increase our inventory following the demand demonstrated by our SHIR and R&G product lines,” said Iris Bincovich, CEO and Co-Founder of Innocan Pharma.
About Innocan
The Company, through its wholly owned Israeli subsidiary, Innocan Pharma Ltd. (“Innocan Israel”), is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD“). Innocan Israel and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the COVID-19 Coronavirus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.
Innocan Israel signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. Innocan Israel plans, together with Professor Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. Innocan Israel is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.
For further information, please contact:
For Innocan Pharma Corporation: Iris Bincovich, CEO +972-54-3012842 [email protected]
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Caution regarding forward-looking information
Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.
Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.
Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.
Posted by AGORACOM-JC
at 12:09 PM on Wednesday, December 16th, 2020
David Lucatch CEO, President & Chair of KABN Systems NA Holding Corp.(KABN:CSE) says their addressable market is 100% of people online due to the fact that every single person online needs to manage their identity. The company empowers users by giving them the tools to manage their self-sovereign identity and data online.
Posted by AGORACOM-JC
at 11:05 AM on Wednesday, December 16th, 2020
Hosting a conference call, today, December 16, 2020 in order to conduct its Annual General Meeting, and for interested investors.
The formal part of the AGM will take approximately ten minutes followed by an update to investors and shareholders on the Company’s operations.
Binovi CEO, Adam Cegielski, will host the call and answer questions from participants.
TORONTO, ON / December 16, 2020 / Binovi Technologies Corp. (Binovi) (OTCQB:BNVIF)(TSX-V:VISN)(FRA:2EYA) is hosting a conference call, today, December 16, 2020 in order to conduct its Annual General Meeting, and for interested investors. The formal part of the AGM will take approximately ten minutes followed by an update to investors and shareholders on the Company’s operations. Binovi CEO, Adam Cegielski, will host the call and answer questions from participants.
Conference Call:
Date: Wednesday, December 16, 2020 Time: 11:15am PST, 2:15pm EST Dial-in: Tollfree – 1 (866) 365 4406.Passcode: 6096110#
Binovi is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. As a SAAS based solution, the Binovi Connect App is supported by specialized expert knowledge, unique data insights and supporting hardware to deliver customized, one-on-one cognitive training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Binovi is currently used in over 20 countries.
Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 11:01 AM on Wednesday, December 16th, 2020
FansUnite will gain first-mover advantage into the U.S. esports betting market through long term partnership with GameCo
Announced its partner, GameCo LLC (“GameCo”), a Las Vegas based pioneer in Video Game Gambling™, has entered into a partnership with US Bookmaking and Sky Ute Casino
To establish the first dedicated esports sportsbook in the United States.
Wholly owned subsidiary Askott Entertainment will supply its iGaming platform, Chameleon, as part of a fully integrated esports betting solution.
Vancouver, British Columbia–(December 16, 2020) – FansUnite Entertainment Inc (CSE: FANS) (OTCQB: FUNFF) (“FansUnite” or the “Company”), a technology company providing leading online gaming solutions, is pleased to announce its partner, GameCo LLC (“GameCo”), a Las Vegas based pioneer in Video Game Gambling™, has entered into a partnership with US Bookmaking and Sky Ute Casino to establish the first dedicated esports sportsbook in the United States. Wholly owned subsidiary Askott Entertainment will supply its iGaming platform, Chameleon, as part of a fully integrated esports betting solution.
Through GameCo’s partnership with Sky Ute Casino and US Bookmaking, FansUnite will be the first iGaming solutions provider to receive significant exposure in the U.S. esports betting market.
As previously announced on September 2nd, 2020, FansUnite entered into a partnership with GameCo to establish a fully integrated turnkey esports betting solution for online casinos and sportsbooks in the United States. Under the agreement with GameCo and Sky Ute Casino, Askott Entertainment’s Chameleon iGaming Platform will form the basis of GameCo’s esports betting offering alongside GRID’s data platform and 10Star’s odds feed and risk management services, resulting in an esports sportsbook with extensive and broad-ranging services that are geared towards the younger demographic of online gamblers.
“We are delighted to be part of the first-ever real money esports sportsbook in the U.S. as it represents a major milestone for FansUnite and the entire betting community globally,” said Scott Burton, CEO of FansUnite Entertainment. “Entering the U.S. market has always been part of our growth roadmap and partnering with GameCo in September represented a channel for us to introduce our leading B2B esports betting solution to a sizable and growing market. This latest customer win has exceeded our own expectations and validates our technology, strategy, and legitimacy of our organization. With our first casino customer now in hand, we are eager to continue our collaboration with GameCo, GRID, and 10 Star to establish a larger presence in the U.S. market.”
Blaine Graboyes, Co-Founder and CEO of GameCo added, “This marks a new era for GameCo as we will be the frontrunners in capturing revenue from an untouched segment in the U.S. online casino market. We require the most innovative technology that will provide a strong backbone for our betting systems and we are pleased that FansUnite is able to fulfill that need with the Chameleon iGaming solutions.”
About FansUnite Entertainment Inc.
FansUnite is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one of a kind complete iGaming platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high-growth potential in new or developing markets.
About GameCo
GameCo LLC creates revolutionary gaming products and experiences that drive growth and deliver a new, different, and younger player for digital and retail casinos. The inventor of the world’s first skill-based Video Game Gambling Machine (VGM™), GameCo’s omnichannel land-based and online platform combines the fun and interactivity of video games with the thrill and anticipation of gambling. Through its iGameCo brand, GameCo develops unique video game gambling titles for digital casinos and provides the first turnkey, outsourced, full-service esports betting solution built specifically for the regulated US market. GameCo’s Video Game Gambling™ platform and patent-pending GamersEdge™ technology enables game developers and publishers to distribute and monetize video games into regulated gaming markets. GameCo offers single player and esports-style multiplayer games with a wide portfolio of sports, casual, and arcade titles that also feature brand licenses from major studios and celebrities such as Steve Aoki from DJ Kid Millionaire LTD., “SOULCALIBUR™II” with BANDAI NAMCO Amusement Inc., and Star Trek™ with CBS Consumer Products, Inc.
GameCo LLC is privately held and headquartered in Las Vegas and currently licensed to operate in more than twenty gaming jurisdictions, including Nevada. For the latest GameCo news, please visit https://gameco.com/product or follow the company on Twitter at twitter.com/GameCoLLC.
For further information, please contact:
Prit Singh Investor Relations at FansUnite [email protected] (905) 510-7636
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-looking information” under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “believes,” “belief,” “expects,” “intends,” ”anticipates,” “potential,” “should,” “may,” “will,” “plans,” “continue” or similar expressions to be uncertain and forward-looking. Forward-looking statements may include, without limitation, statements relating to future outlook and anticipated events such as: the extent and range of FansUnite’s iGaming platform; target demographics of FansUnite; growth of the U.S. market; expansion of FansUnite into the U.S. market; the position of FansUnite and GameCo as frontrunners in the US online casino market; FansUnite’s ability to fulfill technology needs with its platform; GameCo’s ability to enable the distribution and monetization of video games into the licensed gaming market and to attract new customers; business development plans of FansUnite and GameCo; the Company’s unique portfolio of assets; and discussion of future plans, projections, objectives, estimates and forecasts and the timing related thereto. Forward-looking statements are based on the Company’s estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of FansUnite to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Additional information regarding the risks and uncertainties relating to the Company’s business are contained under the heading “Risk Factors” in the Company’s Non-Offering Prospectus dated March 27, 2020 filed on its issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, including the novel coronavirus (COVID-19) global health pandemic, and the spread of other viruses or pathogens and influence of macroeconomic developments. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The forward-looking statements in this news release are made as of the date of this release. FansUnite disclaims and does not undertake to update or revise any forward-looking statements or forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.
Posted by AGORACOM-JC
at 8:45 AM on Wednesday, December 16th, 2020
Further to its press releases dated April 1 st and 21 st , 2020, it has signed an additional contract (the “Contract”) with a US based tunneling client (the “Client”) for approx. $1.1MM.
The total value of all contracts, including the one announced today, entered into with the Client is in excess of $3.6MM.
The Company has received $1.3MM to date under these contracts.
The Client’s name will remain confidential for competitive reasons.
MONTREAL, Dec. 16, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that, further to its press releases dated April 1 st and 21 st , 2020, it has signed an additional contract (the “Contract”) with a US based tunneling client (the “Client”) for approx. $1.1MM. The total value of all contracts, including the one announced today, entered into with the Client is in excess of $3.6MM. The Company has received $1.3MM to date under these contracts. The Client’s name will remain confidential for competitive reasons.
Based on these contracts, PyroGenesis will be designing, manufacturing, testing and supplying the Client with a plasma torch tailored specifically for tunneling (the “TT1 Torch”). The TT1 Torch is expected to be delivered in the second half of 2021, at which time it will then be tested. The Client is committed to purchase exclusively from PyroGenesis, and the Company is committed to exclusively supply the Client with plasma torches and auxiliary equipment for tunneling applications.
PyroGenesis’ high-powered plasma torch will be used to replace traditional tunneling methods. An important benefit in using plasma-based tools versus traditional methods is its potential to drill through all geologies with greater flexibility in size diameter, while at the same time being more economical, efficient and environmentally friendly.
“This is the second announcement PyroGenesis has made in as many months which highlight advances in our plasma torch offerings,” said Mr. P Peter Pascali, CEO and Chair of PyroGenesis. “As you can see, not only are our torch offerings steadily moving forward, but are doing so in totally independent applications. This bodes well for the future and once again, underscores both the interest in, and versatility of, our torch offerings which at the same time are being recognized as effective environmental solutions.”
About PyroGenesis Canada Inc
PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m 2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found atwww.sedar.com,or atwww.otcmarkets.com.Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact: Rodayna Kafal, Vice President, IR/Comms. and Strategic BD Phone: (514) 937-0002, E-mail: [email protected]
Posted by AGORACOM-JC
at 8:41 AM on Wednesday, December 16th, 2020
Announced that it has received subscription confirmations for over $2 Million of units pursuant to the non-brokered financing announced on December 10, 2020, which is expected to close prior to the unrelated, best efforts brokered private placement of units which the Company previously announced on December 7, 2020.
To support the current demand, the Company has upsized the Non-Brokered Offering by an additional $1 Million.
This amount has already been fully committed, subject to the receipt of outstanding subscription documents and all necessary approvals.
TORONTO, ON / December 16, 2020 /KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America” or “KABN NA“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has received subscription confirmations for over $2 Million of units (“Units“) pursuant to the non-brokered financing (the “Non-Brokered Offering“) announced on December 10, 2020, which is expected to close prior to the unrelated, best efforts brokered private placement (the “Brokered Offering“) of units which the Company previously announced on December 7, 2020. To support the current demand, the Company has upsized the Non-Brokered Offering by an additional $1 Million. This amount has already been fully committed, subject to the receipt of outstanding subscription documents and all necessary approvals.
The gross proceeds of these unrelated offerings together will now be up to $4.15 Million. The Units in each of the Brokered Offering and Non-Brokered Offering are being offered at $0.15 per Unit, with each Unit comprised of one common share of the Company (a “Common Share“) and one Common Share purchase warrant (a “Warrant“). Each Warrant shall be exercisable to acquire one Common Share (a “Warrant Share“) at an exercise price of $0.20 per Warrant Share for a period of 24 months from the applicable closing.
The Brokered Offering is expected to close on or about December 29, 2020, or on such earlier date as agreed upon between the Company and Agent, and the Non-Brokered Offering is expected to close on or about December 21, 2020, or on such earlier or later date as the Company determines, and each is subject to certain conditions, including receipt of subscription agreements and payment of the subscription amounts by subscribers. The Units to be issued will have a hold period of four months and one day from the applicable closing.
The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws, and accordingly, may not be offered or sold within the United States except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities requirements or pursuant to exemptions therefrom. This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction.
The Company also announces that Mr. Rav Mlait has resigned from the Board of Directors to further focus his efforts on his current commitments. The Company thanks Mr. Mlait for all his support with the public listing process earlier this year, and wishes him well in his current and future endeavors.
About KABN North America KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from the use of their online identity. KABN NA’s propriety technology suite includes 4 key products:
Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allow users to manage and control their Self Sovereign Identity and to use Liquid Avatars to share verifiable credentials, including access, identity and designation credentials, and public and permission based private data when they want and with whom they want.
KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.
KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives.
KABN KASH is a cashback, loyalty and engagement program that powers the KABN NA’s revenue ecosystem. KABN NA provides its products and services at no cost to consumers and generates revenues through permission-based partner programs.
Posted by AGORACOM-JC
at 7:28 AM on Wednesday, December 16th, 2020
Announced the release of Nexalogy SMART – Social Media Automated Reporting Technology
As previously announced, Nexalogy’s SMART is an advanced proprietary AI technology
SMART minimizes human involvement in data analysis and reporting.
It significantly decreases the time required for integration and interpretation of large data sets and report production
Now fully available
Toronto, Ontario–(December 16, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce the release of Nexalogy SMART – Social Media Automated Reporting Technology.
As previously announced, Nexalogy’s SMART is an advanced proprietary AI technology. SMART minimizes human involvement in data analysis and reporting. It significantly decreases the time required for integration and interpretation of large data sets and report production. It is now fully available.
SMART takes NexaIntelligence to the next level with AI-powered automated reporting technology. It quickly generates reports with all of NexaIntelligence’s visualizations, augmenting the reporting capacity of analysts. Human resources are a scarce commodity. SMART integrates larger sets of data into smaller, more manageable reports, thus significantly reducing the number of resource hours required to identify insights.
Our AI pre-reads text, selects verbatims, and summarizes themes quickly, reliably, and with precision. The AI technology creates powerful reports based on our algorithms and automatically selects the most important original posts to include, in minutes rather than hours. Analysts can specify filters on the data to get automatic reports on subsets of the data focusing on specific times, entities, social media users, or topics. This means social media trends can be understood faster and with less difficulty, keeping companies ahead of the curve.
SMART’s scheduling functionality allows companies to structure reporting to match regular schedules as needed or in response to triggering events in the data itself. AI-written reports are emailed to analysts inconvenient and easy to read file formats, such as MSWORD or PDF. Raw JSON outputs from Nexalogy’s API are also available for use in white labelled products.
AI reporting on social media and other forms of unstructured text is increasingly important and relevant in the information landscape. The need for strategic reporting of data from these platforms in both the public and private sectors is growing at a rapid pace. The ability to analyze and monetize social media discussions, as well as unstructured text from owned sources, are key strengths of SMART. Breaking through information bottlenecks and resource limitations, SMART can take big data discovery and exploration to a new level of actionable insights.
“Our AI helps you unlock the power of discovery, converting unknown unknowns into known knowns, activating the hidden potential currently lost in big data. With social media and unstructured text being a key facet of how businesses and consumers connect during the pandemic, we feel SMART is uniquely positioned to assist clients in unlocking potential in current verticals and exploring the potential of new verticals; for security, we help you discover unknown problems so you can squash them before they become big problems. For growth, we help you discover and unlock hidden potential,” said Marshall Gunter, CEO of Datametrex AI Limited.
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.
For further information, please contact: Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor it Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 7:22 AM on Wednesday, December 16th, 2020
Company’s board of directors has authorized management to review the process to graduate the Company from the CSE to the TSX
If the Company is successful in uplisting to the TSX, Kontrol intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement with the Securities and Exchange Commission of the United States, which will enable Kontrol to apply to be listed on the NASDAQ
TORONTO, ON / December 16, 2020 / Kontrol Energy Corp.(CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“), a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce that it has completed its previously announced debenture exchange (see press release dated June 9, 2020 and November 2, 2020) by private placement. The 2020 Debenture holders exchanged a total of $3,650,000 for 2022 Debentures and new proceeds of $871,000 were raised. The remaining 2020 Debenture balance of $2,061,000 was redeemed in cash by the Company. Each unit is comprised of one $1,000 8% unsecured debenture (and non-convertible) of the Company maturing on October 31, 2022 and 10 common shares.
Paul Ghezzi, CEO of Kontrol, commented:
“With the exchange of the 2020 Debentures we have improved the balance sheet and the Company’s net equity position. As we continue to execute on our business plan, we believe this is an opportune time to begin the graduation process to the senior North American exchanges for an uplisting in 2021.”
Name Change
Further to the passing of a resolution of shareholders at its most recent general and special meeting of shareholders, the Company intends to proceed with a corporate name change to “Kontrol Technologies Corp.”, which is anticipated to be completed prior to December 31, 2020.
Uplisting to TSX, NASDAQ
The Company’s board of directors has authorized management to review the process to graduate the Company from the CSE to the TSX. If the Company is successful in uplisting to the TSX, Kontrol intends to, as soon as practical, begin the process of filing a Form F-1 Registration Statement with the Securities and Exchange Commission of the United States (the “SEC“), which will enable Kontrol to apply to be listed on the NASDAQ.
Completion of any uplisting is subject to meeting certain conditions, as well as the approval of the TSX. There is no assurance that the TSX will approve the listing application or that Kontrol will complete the uplisting as contemplated. There is no assurance that either the SEC or NASDAQ will approve the Company’s respective applications or that Kontrol will complete the listing to the NASDAQ as proposed.
About Kontrol Energy
Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com
For further information, contact:
Paul Ghezzi, Chief Executive Officer [email protected] or [email protected] Kontrol Energy Corp. 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Posted by AGORACOM-JC
at 8:38 PM on Tuesday, December 15th, 2020
Entered into a technology integration agreement with LiveCare Corp. and a Value-Added Reseller and Distribution Agreement with Alliance Tele-Med, to provide integrated ECG monitoring through the LiveCare Link+ device and telemedicine platform.
CardioComm confirms integration of their FDA and Health Canada cleared GEMS™ ECG management software, the wireless HeartCheck™ CardiBeat ECG monitor and access to the SMART Monitoring ECG reading service into the Link+ platform has been completed.
Under the agreement, the GEMS™ Mobile app technology was embedded into the Link+ gateway device allowing ECGs to be transferred through the Link+ platform to the CardioComm SMART Monitoring ECG reading service.
Once an ECG report is completed, the report findings are then securely transmitted to the Link+ platform and from there to the Link+ platform’s remote patient monitoring teams.
TORONTO, ON / December 15, 2020 / CardioComm Solutions, Inc.(TSXV:EKG) (“CardioComm” or the “Company“), a global provider of consumer heart monitoring and electrocardiogram (“ECG“) device and software solutions, is pleased to confirm it has entered into a technology integration agreement with LiveCare Corp. (“LiveCare“) and a Value-Added Reseller and Distribution Agreement with Alliance Tele-Med (“Alliance“), to provide integrated ECG monitoring through the LiveCare Link+ device and telemedicine platform.
CardioComm confirms integration of their FDA and Health Canada cleared GEMS™ ECG management software, the wireless HeartCheck™ CardiBeat ECG monitor and access to the SMART Monitoring ECG reading service into the Link+ platform has been completed. Under the agreement, the GEMS™ Mobile app technology was embedded into the Link+ gateway device allowing ECGs to be transferred through the Link+ platform to the CardioComm SMART Monitoring ECG reading service. Once an ECG report is completed, the report findings are then securely transmitted to the Link+ platform and from there to the Link+ platform’s remote patient monitoring teams.
Link+ is a patented smart home gateway that integrates multiple key medical bio-sign monitoring devices in a patient’s home through a proprietary, touch-free device which is always connected to the 4G network. There is no need for patients to connect to any specific Wi-Fi network for the Link+ to fully operate and, once activated, the Link+ transmits data directly to LiveCare’s HIPAA compliant cloud. The Link+ is fully reimbursable through Medicare, Medicaid and many commercial insurance plans using multiple CPT codes.
Through the addition of the GEMS™ technology into the Link+ gateway device, the Link+ device will be capable of recognizing multiple ECG devices with up to 12 leads of ECG recording and provide Link+ customers with more options in choosing a device of their preference. The HeartCheck™ CardiBeat will be the recommended device for remote ECG patient monitoring given its availability in Canada, the US and Europe. All recorded ECGs will be passed through CardioComm’s SMART Monitoring ECG triaging service. ECG reports confirming the presence or absence of an arrhythmia will be provided to Link+ users.
The Link+ platform with ECG monitoring sales and marketing will be undertaken exclusively by Alliance with a focus on monitoring patients with or suspected to have COVID-19. Sales into the US is where the primary marketing efforts are targeted for 2021. CardioComm will see revenue from the sales of the HeartCheck™ CardiBeat ECG devices as well as from ECG triaging service fees.
To learn more about CardioComm’s products and for further updates regarding HeartCheck™ ECG device integrations please visit the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com.
About CardioComm Solutions
CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. CardioComm Solutions has earned the ISO 13485:2016 MDSAP certification, is HIPAA compliant and holds clearances from the European Union (CE Mark), the USA (FDA) and Canada (Health Canada).
About LiveCare (www.livecareusa.com)
LiveCare’s mission is to improve patient outcomes, lower healthcare costs, and reduce hospital readmissions by developing technology to assist patients and providers during the critical transitional care period. LiveCare’s technology improves patient compliance with post-discharge medical protocols and enhances engagement between patients and providers. With a team of experienced professionals working in research and development, sales, and other capacities, LiveCare is putting the needs of patients and providers at the forefront as it moves the RPM market forward from its corporate headquarters in New York City.
About Alliance-Telemed, LLC
Alliance Tele-Med is a US-based Value-Added Wholesaler & Reseller of state-of-the-art remote patient monitoring (RPM) technology and care management services solutions for domestic and international healthcare delivery organizations and their patients. The company engages with healthcare and life sciences organizations such as Independent and Hospital-Owned Medical Practices, Independent Hospitals and Health Systems, Accountable Care Organizations (ACO’S), Independent Physician Associations (IPA’s), Provider Networks, large Employer Groups and Third Party Administrators, Clinics, FQHC and Regional Health Centers, Senior ‘Aging in Place’ Companies and Facilities such as Assisted Living Facilities, Nursing Homes, Skilled Nursing Facilities, Home Health Companies, pharmaceutical companies, and Clinical Research Organizations (CRO’s).
This release may contain certain forward-looking statements and forward-looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.
In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
